AmerisourceBergen Corp. (ABC) EVP Sells $270,000.00 in Stock
AmerisourceBergen Corp. (NYSE:ABC) EVP Robert P. Mauch sold 3,000 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $90.00, for a total value of $270,000.00. Following the completion of the transaction, the executive vice president now directly owns 14,531 shares in the company, valued at $1,307,790. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
AmerisourceBergen Corp. (ABC) traded up $3.86 on Friday, hitting $93.17. The stock had a trading volume of 4,153,406 shares, compared to its average volume of 1,795,618. The company has a market capitalization of $19,295.90, a PE ratio of 15.02, a PEG ratio of 1.53 and a beta of 1.00. The company has a current ratio of 0.91, a quick ratio of 0.48 and a debt-to-equity ratio of 1.83. AmerisourceBergen Corp. has a 1-year low of $71.90 and a 1-year high of $97.85.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.32 by $0.01. The business had revenue of $39.12 billion for the quarter, compared to analysts’ expectations of $40.10 billion. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. AmerisourceBergen’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.30 earnings per share. analysts anticipate that AmerisourceBergen Corp. will post 6.07 earnings per share for the current year.
Several brokerages have commented on ABC. Cowen raised AmerisourceBergen from a “market perform” rating to an “outperform” rating in a research report on Tuesday, October 10th. Jefferies Group set a $85.00 price target on AmerisourceBergen and gave the stock a “hold” rating in a research report on Sunday, October 29th. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Tuesday, October 3rd. Goldman Sachs Group raised AmerisourceBergen from a “neutral” rating to a “buy” rating in a research report on Friday. Finally, Robert W. Baird set a $99.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a research report on Friday, December 1st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. AmerisourceBergen presently has an average rating of “Buy” and a consensus price target of $93.20.
Several institutional investors and hedge funds have recently added to or reduced their stakes in ABC. First Merchants Corp boosted its stake in AmerisourceBergen by 160.5% in the 3rd quarter. First Merchants Corp now owns 27,342 shares of the company’s stock valued at $2,262,000 after buying an additional 16,848 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its stake in AmerisourceBergen by 23.3% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,459 shares of the company’s stock valued at $369,000 after buying an additional 842 shares in the last quarter. Wedge Capital Management L L P NC boosted its stake in AmerisourceBergen by 17.3% in the 3rd quarter. Wedge Capital Management L L P NC now owns 494,216 shares of the company’s stock valued at $40,896,000 after buying an additional 72,743 shares in the last quarter. Achmea Investment Management B.V. boosted its stake in AmerisourceBergen by 7.8% in the 2nd quarter. Achmea Investment Management B.V. now owns 29,338 shares of the company’s stock valued at $2,770,000 after buying an additional 2,123 shares in the last quarter. Finally, Burgundy Asset Management Ltd. boosted its stake in AmerisourceBergen by 3.3% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 2,649,123 shares of the company’s stock valued at $250,422,000 after buying an additional 84,163 shares in the last quarter. Institutional investors and hedge funds own 67.94% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was first published by American Banking News and is owned by of American Banking News. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/12/15/amerisourcebergen-corp-abc-evp-sells-270000-00-in-stock.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.